These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 10077757

  • 1. Gastro-oesophageal reflux and Helicobacter pylori.
    Pace F, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S289-93. PubMed ID: 10077757
    [Abstract] [Full Text] [Related]

  • 2. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
    Weston AP, Badr AS, Topalovski M, Cherian R, Dixon A, Hassanein RS.
    Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
    [Abstract] [Full Text] [Related]

  • 3. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus.
    Vaezi MF, Falk GW, Peek RM, Vicari JJ, Goldblum JR, Perez-Perez GI, Rice TW, Blaser MJ, Richter JE.
    Am J Gastroenterol; 2000 Sep; 95(9):2206-11. PubMed ID: 11007219
    [Abstract] [Full Text] [Related]

  • 4. Eradication of Helicobacter pylori might halt the progress to oesophageal adenocarcinoma in patients with gastro-oesophageal reflux disease and Barrett's oesophagus.
    Kountouras J, Chatzopoulos D, Zavos C.
    Med Hypotheses; 2007 Sep; 68(5):1174-5. PubMed ID: 17196756
    [No Abstract] [Full Text] [Related]

  • 5. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
    Rauws EA.
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
    [Abstract] [Full Text] [Related]

  • 6. Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
    Gisbert JP, Pajares JM, Losa C.
    Hepatogastroenterology; 1999 Dec; 46(26):1023-9. PubMed ID: 10370661
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Barrett's esophagus and the presence of Helicobacter pylori.
    Henihan RD, Stuart RC, Nolan N, Gorey TF, Hennessy TP, O'Morain CA.
    Am J Gastroenterol; 1998 Apr; 93(4):542-6. PubMed ID: 9576445
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
    Muramatsu A, Azuma T, Okajima T, Ohtani M, Dojo M, Yamazaki Y, Kuriyama M.
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
    [Abstract] [Full Text] [Related]

  • 12. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A, Celikel CA, Ozdogan O, Tözün N, Ulusoy NB, Kalayci C.
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
    [Abstract] [Full Text] [Related]

  • 13. Long-term acid suppression by omeprazole in gastro-oesophageal reflux disease patients does not lead to anti-gastric autoantibody production.
    Bergman MP, Klinkenberg-Knol EC, Faller G, Aar A, Lakhai W, Vandenbroucke-Grauls CM, Kuipers EJ, Appelmelk BJ.
    Aliment Pharmacol Ther; 2005 Apr 15; 21(8):977-83. PubMed ID: 15813833
    [Abstract] [Full Text] [Related]

  • 14. [Barrett's esophagus and Helicobacter pylori].
    Sakata H, Fujimoto K.
    Nihon Rinsho; 2005 Aug 15; 63(8):1383-6. PubMed ID: 16101226
    [Abstract] [Full Text] [Related]

  • 15. Helicobacter pylori infection and the risk of adenocarcinoma of the esophagus.
    Celiński K, Słomka M, Kasztelan-Szczerbińska B, Madro A, Cichoz-Lach H, Kurzeja A.
    Ann Univ Mariae Curie Sklodowska Med; 2004 Aug 15; 59(1):424-7. PubMed ID: 16146024
    [Abstract] [Full Text] [Related]

  • 16. [Gastroesophageal reflux disease and Helicobacter pylori infection].
    Naumovski-Mihalić S, Sabarić B, Filipec T, Tićak M, Prskalo M, Skurla B, Papa B, Dominis M, Katicić M.
    Lijec Vjesn; 2002 Sep 15; 124 Suppl 1():52-6. PubMed ID: 12592818
    [Abstract] [Full Text] [Related]

  • 17. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
    Delaney B, McColl K.
    Aliment Pharmacol Ther; 2005 Aug 15; 22 Suppl 1():32-40. PubMed ID: 16042657
    [Abstract] [Full Text] [Related]

  • 18. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y, Higuchi K, Nebiki H, Chono S, Uno H, Kitada K, Satoh H, Nakagawa K, Kobayashi K, Tominaga K, Watanabe T, Oshitani N, Arakawa T.
    Aliment Pharmacol Ther; 2005 Jun 15; 21 Suppl 2():10-8. PubMed ID: 15943841
    [Abstract] [Full Text] [Related]

  • 19. Pathogenesis of gastro-oesophageal reflux disease: what role do Helicobacter pylori and host genetic factors play?
    Chourasia D, Ghoshal UC.
    Trop Gastroenterol; 2008 Jun 15; 29(1):13-9. PubMed ID: 18564661
    [Abstract] [Full Text] [Related]

  • 20. Review article: influence of Helicobacter pylori on gastro-oesophageal reflux disease in Japan.
    Haruma K.
    Aliment Pharmacol Ther; 2004 Dec 15; 20 Suppl 8():40-4. PubMed ID: 15575872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.